These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35237704)

  • 1. Prevalence of Latent Tuberculous Infection in Patients With Nontuberculous Mycobacterial Lung Disease and Colonization: A Prospective Study in an Intermediate Tuberculosis Burden Country.
    Lee HS; Wei YF; Tsai YJ; Wang PH; Chen CY; Pan SW; Shu CC
    Open Forum Infect Dis; 2022 Mar; 9(3):ofac072. PubMed ID: 35237704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Biologics and mycobacterial diseases].
    Tsuyuguchi K; Matsumoto T
    Kekkaku; 2013 Mar; 88(3):337-53. PubMed ID: 23672175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk factors of non-tuberculous mycobacterial pulmonary isolates and infection in interstitial lung disease associated with systemic autoimmune disease.
    Shu CC; Chen PS; Lin ZH; Hsiao CT; Kuo CC; Chiang HY; Wu PC
    Clin Exp Rheumatol; 2024 May; 42(5):1006-1014. PubMed ID: 38179726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct clinical features in nontuberculous mycobacterial disease with or without latent tuberculosis infection.
    Siddiqi UR; Chagan-Yasutan H; Nakajima C; Saitoh H; Ashino Y; Usami O; Shiratori B; Usuzawa M; Suzuki Y; Hattori T
    Tohoku J Exp Med; 2012 Apr; 226(4):313-9. PubMed ID: 22522388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating mitochondrial cell-free DNA dynamics in patients with mycobacterial pulmonary infections: Potential for a novel biomarker of disease.
    Pan SW; Syed RR; Catanzaro DG; Ho ML; Shu CC; Tsai TY; Tseng YH; Feng JY; Chen YM; Su WJ; Catanzaro A; Rodwell TC
    Front Immunol; 2022; 13():1040947. PubMed ID: 36466831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in plasma proteomes for active tuberculosis, latent tuberculosis and non-tuberculosis mycobacterial lung disease patients with and without ESAT-6/CFP10 stimulation.
    Teklu T; Wondale B; Taye B; Hailemariam M; Bekele S; Tamirat M; Zewude A; Mohamed T; Medhin G; Legesse M; Yu Y; Ameni G; Pieper R
    Proteome Sci; 2020 Oct; 18(1):10. PubMed ID: 33292280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of nontuberculous mycobacterial lung disease in critically ill patients: Significance for survival and ventilator use.
    Chien YC; Chang CH; Huang CK; Chen YH; Liu CJ; Chen CY; Wang PH; Shu CC; Kuo LC; Wang JY; Ku SC; Wang HC; Yu CJ
    J Microbiol Immunol Infect; 2024 Apr; 57(2):328-336. PubMed ID: 38220536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Soluble T-Cell Immunoglobulin Mucin Domain-3 in Differentiating Nontuberculous Mycobacterial Lung Disease from Pulmonary Colonization.
    Pan SW; Shu CC; Lee CC; Feng JY; Chan YJ; Chen YM; Su WJ
    Arch Bronconeumol; 2022 Jul; 58(7):547-553. PubMed ID: 35312611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and prognosis of nontuberculous mycobacterial lung disease with different radiographic patterns.
    Shu CC; Lee CH; Hsu CL; Wang JT; Wang JY; Yu CJ; Lee LN;
    Lung; 2011 Dec; 189(6):467-74. PubMed ID: 21956280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Soluble T-Cell Immunoglobulin Mucin Domain-3 in Differentiating Nontuberculous Mycobacterial Lung Disease from Pulmonary Colonization.
    Pan SW; Shu CC; Lee CC; Feng JY; Chan YJ; Chen YM; Su WJ
    Arch Bronconeumol (Engl Ed); 2021 Feb; ():. PubMed ID: 33745754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjunctive biomarkers for improving diagnosis of tuberculosis and monitoring therapeutic effects.
    Hur YG; Kang YA; Jang SH; Hong JY; Kim A; Lee SA; Kim Y; Cho SN
    J Infect; 2015 Apr; 70(4):346-55. PubMed ID: 25452040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative chest computed tomography findings of non-tuberculous mycobacterial lung diseases and pulmonary tuberculosis in patients with acid fast bacilli smear-positive sputum.
    Yuan MK; Chang CY; Tsai PH; Lee YM; Huang JW; Chang SC
    BMC Pulm Med; 2014 Apr; 14():65. PubMed ID: 24755048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberculosis and non-tuberculous mycobacteria among HIV-infected individuals in Ghana.
    Bjerrum S; Oliver-Commey J; Kenu E; Lartey M; Newman MJ; Addo KK; Hilleman D; Andersen AB; Johansen IS
    Trop Med Int Health; 2016 Sep; 21(9):1181-90. PubMed ID: 27383726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk adjustment model for tuberculosis compared to non-tuberculosis mycobacterium or latent tuberculosis infection: Center for Personalized Precision Medicine of Tuberculosis (cPMTb) cohort database.
    Seo WJ; Koo HK; Kang JY; Kang J; Park SH; Kang HK; Park HK; Lee SS; Choi S; Jang TW; Shin KC; Oh JY; Choi JY; Min J; Choi YK; Shin JG; Cho YS
    BMC Pulm Med; 2023 Nov; 23(1):471. PubMed ID: 38001469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma inducible protein 10 as a biomarker for active tuberculosis and latent tuberculosis infection in children: a case-control study.
    Alsleben N; Ruhwald M; Rüssmann H; Marx FM; Wahn U; Magdorf K
    Scand J Infect Dis; 2012 Apr; 44(4):256-62. PubMed ID: 22103555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The trend and the disease prediction of vascular endothelial growth factor and placenta growth factor in nontuberculous mycobacterial lung disease.
    Lin CH; Shu CC; Hsu CL; Cheng SL; Wang JY; Yu CJ; Lee LN
    Sci Rep; 2016 Nov; 6():37266. PubMed ID: 27876856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of clinical and laboratory findings between those with pulmonary tuberculosis and those with nontuberculous mycobacterial lung disease.
    Thanachartwet V; Desakorn V; Duangrithi D; Chunpongthong P; Phojanamongkolkij K; Jitruckthai P; Kasetjaroen Y; Pitisuttithum P
    Southeast Asian J Trop Med Public Health; 2014 Jan; 45(1):85-94. PubMed ID: 24964657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease Progression in Patients With Nontuberculous Mycobacterial Lung Disease of Nodular Bronchiectatic (NB) Pattern: The Roles of Cavitary NB and Soluble Programmed Death Protein-1.
    Pan SW; Su WJ; Chan YJ; Ho ML; Feng JY; Shu CC; Wang JY; Wang HC; Yu CJ; Chen YM
    Clin Infect Dis; 2022 Aug; 75(2):239-247. PubMed ID: 34726741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics associated with progression in patients with of nontuberculous mycobacterial lung disease : a prospective cohort study.
    Kim SJ; Yoon SH; Choi SM; Lee J; Lee CH; Han SK; Yim JJ
    BMC Pulm Med; 2017 Jan; 17(1):5. PubMed ID: 28056937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of latent tuberculosis infection among pre-clinical and clinical medical students using QuantiFERON-TB gold plus and tuberculin skin test at a teaching hospital in Thailand: A cross-sectional study.
    Chumpa N; Kawkitinarong K; Wongpiyabovorn J; Paitoonpong L; Suwanpimolkul G
    J Infect Public Health; 2022 Apr; 15(4):400-405. PubMed ID: 35325687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.